Hyperferritinaemia has been recognized as an independent risk factor for poor prognosis in patients with anti-MDA5+ IIM-ILD (35, 49, 54) and in those with ASS-ILD (55). The gene discussed is IFIH1; the disease is interstitial lung disease.